These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 12593629

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Multiparametric ISODATA analysis of embolic stroke and rt-PA intervention in rat.
    Ding G, Jiang Q, Zhang L, Zhang Z, Knight RA, Soltanian-Zadeh H, Lu M, Ewing JR, Li Q, Whitton PA, Chopp M.
    J Neurol Sci; 2004 Aug 30; 223(2):135-43. PubMed ID: 15337614
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of sonothrombolysis in a rat model of embolic ischemic stroke.
    Daffertshofer M, Huang Z, Fatar M, Popolo M, Schroeck H, Kuschinsky W, Moskowitz MA, Hennerici MG.
    Neurosci Lett; 2004 May 06; 361(1-3):115-9. PubMed ID: 15135907
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
    Lu HT, Zhao JG, Li MH, Li YD.
    Brain Res; 2012 Feb 15; 1438():75-84. PubMed ID: 22227456
    [Abstract] [Full Text] [Related]

  • 27. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
    Zhang L, Zhang ZG, Zhang R, Morris D, Lu M, Coller BS, Chopp M.
    Circulation; 2003 Jun 10; 107(22):2837-43. PubMed ID: 12756151
    [Abstract] [Full Text] [Related]

  • 28. Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: comparison with tissue plasminogen activator.
    Furuichi Y, Maeda M, Matsuoka N, Mutoh S, Yanagihara T.
    Exp Neurol; 2007 Mar 10; 204(1):138-46. PubMed ID: 17169359
    [Abstract] [Full Text] [Related]

  • 29. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator.
    Lapchak PA, Zivin JA.
    Stroke; 2003 Aug 10; 34(8):2013-8. PubMed ID: 12855833
    [Abstract] [Full Text] [Related]

  • 30. Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat.
    Zhang RL, Zhang ZG, Chopp M.
    Neurology; 1999 Jan 15; 52(2):273-9. PubMed ID: 9932943
    [Abstract] [Full Text] [Related]

  • 31. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
    Yang Y, Li Q, Shuaib A.
    Exp Neurol; 2000 May 15; 163(1):39-45. PubMed ID: 10785442
    [Abstract] [Full Text] [Related]

  • 32. Role of MC-1 alone and in combination with tissue plasminogen activator in focal ischemic brain injury in rats.
    Wang CX, Yang T, Noor R, Shuaib A.
    J Neurosurg; 2005 Jul 15; 103(1):165-9. PubMed ID: 16121987
    [Abstract] [Full Text] [Related]

  • 33. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].
    Kirchhof K, Sikinger M, Welzel T, Zoubaa S, Sartor K.
    Rofo; 2004 Jan 15; 176(1):98-105. PubMed ID: 14712413
    [Abstract] [Full Text] [Related]

  • 34. THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models.
    Krakovsky M, Polianski V, Nimrod A, Higazi A, Leker RR, Lamensdorf I.
    Neurol Res; 2011 Nov 15; 33(9):983-90. PubMed ID: 22081002
    [Abstract] [Full Text] [Related]

  • 35. Enhanced poly(ADP-ribose) polymerase-1 activation contributes to recombinant tissue plasminogen activator-induced aggravation of ischemic brain injury in vivo.
    Crome O, Doeppner TR, Schwarting S, Müller B, Bähr M, Weise J.
    J Neurosci Res; 2007 Jun 15; 85(8):1734-43. PubMed ID: 17455321
    [Abstract] [Full Text] [Related]

  • 36. Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate-containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats.
    Tiebosch IA, Crielaard BJ, Bouts MJ, Zwartbol R, Salas-Perdomo A, Lammers T, Planas AM, Storm G, Dijkhuizen RM.
    J Neurochem; 2012 Nov 15; 123 Suppl 2():65-74. PubMed ID: 23050644
    [Abstract] [Full Text] [Related]

  • 37. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
    Petty MA, Neumann-Haefelin C, Kalisch J, Sarhan S, Wettstein JG, Juretschke HP.
    Eur J Pharmacol; 2003 Aug 01; 474(1):53-62. PubMed ID: 12909195
    [Abstract] [Full Text] [Related]

  • 38. Low dose tPA plus annexin A2 combination attenuates tPA delayed treatment-associated hemorrhage and improves recovery in rat embolic focal stroke.
    Jiang Y, Fan X, Yu Z, Cheng C, Wang XS, Lo EH, Sun X, Wang X.
    Neurosci Lett; 2015 Aug 18; 602():73-8. PubMed ID: 26149229
    [Abstract] [Full Text] [Related]

  • 39. Rt-PA causes a significant increase in endogenous u-PA during experimental focal cerebral ischemia.
    Burggraf D, Martens HK, Wunderlich N, Jäger G, Hamann GF.
    Eur J Neurosci; 2004 Dec 18; 20(11):2903-8. PubMed ID: 15579144
    [Abstract] [Full Text] [Related]

  • 40. MRI evaluation of treatment of embolic stroke in rat with intra-arterial and intravenous rt-PA.
    Jiang Q, Zhang ZG, Zhang L, Ding GL, Li L, Ewing JR, Lu M, Whitton P, Hu J, Li QJ, Zhang RL, Chopp M.
    J Neurol Sci; 2004 Sep 15; 224(1-2):57-67. PubMed ID: 15450772
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.